Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2023

Aug 7, 2023

34472_dirs_2023-08-07_f3f95101-3fd6-44d5-9ccb-42d90d4874b0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-08-03

Reporting Person: Kennedy Lawrence T. Jr (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-03 Common Stock A 6172839 $1.62 Acquired 10528753 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9582783 Indirect
Common Stock 166666 Indirect
Common Stock 722041 Indirect

Footnotes

F1: Reported amounts have been adjusted to reflect the March 13, 2023 transfer of 433,894 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.